Alexis Retractor in Total Hip Arthroplasty
This study is looking at two different surgical tools, the Alexis wound retractor and a standard wound retractor, used during total hip replacement surgery (total hip arthroplasty). The goal is to see if using the Alexis wound retractor helps with wound healing and reduces the chance of infection after surgery. Researchers will compare how quickly wounds heal and how satisfied patients are with their scars up to 12 months after surgery. You may be able to join if you are having your first total hip replacement on one hip using a specific surgical approach. The study is currently recruiting 202 participants, but its overall status is unclear.
- Study design
- This study is an interventional study, meaning participants will receive one of the two surgical retractors. It plans to enroll 202 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for up to 14 days for wound healing and up to 12 months for scar satisfaction and appearance.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Alexis Retractor in Total Hip Arthroplasty
At a glance
Conditions
NCT07237737
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Miami
Miami, Floridastudy coordinator listed
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Victor H Hernandez, MD, MSc · PRINCIPAL_INVESTIGATOR · University of Miami Department of Orthopaedics
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of Days to Identification of Delayed Wound HealingUp to 14 days
Delayed wound healing is defined as the presence of one or more of the following clinical signs: drainage from wound, wound dehiscence, and superficial surgical site infection. Assessment is performed by clinical examination and documentation in the postoperative period. The outcome is measured in number of days from surgery to identification of delayed healing
- Patient satisfaction with scaring as measured by Patient Scar Assessment ScaleUp to 12 months
Using the Patient Scar Assessment Scale, which is a validated plastic surgery tool for evaluating scars from the patient's perspective. Measured with a scale from 0 to 10, higher score indicates less satisfaction.
- Scar cosmesis as measured by Observer Scar Assessment ScaleUp to 12 months
Using the Observer Scar Assessment Scale, which is a validated plastic surgery tool for evaluating scars from the observer perspective. Measured with a scale from 0 to 10, higher score indicates worse scar cosmesis.